Aurobindo Pharma gets DCGI nod for Molnupiravir generic version

pallavi123- December 29, 2021 0

Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More

Dr. Reddy’s secures EUA for Sputnik V vaccine in India for Covid-19 prevention

pallavi123- April 13, 2021 0

Dr. Reddy’s Laboratories has secured permission from the Drug Controller General of India (DCGI) for importing the Sputnik V vaccine into India under emergency use ... Read More

Dr. Reddy’s Laboratories gets DCGI nod for phase 3 trial of Sputnik V vaccine

pharmanewsdaily- January 16, 2021 0

Dr. Reddy’s Laboratories has secured the go-ahead from the Drugs Control General of India (DCGI) to begin phase 3 clinical trial for the Russian Covid-19 ... Read More

Dr. Reddy’s reports success for Russian Covid-19 vaccine Sputnik V

pharmanewsdaily- January 14, 2021 0

Indian pharma company Dr. Reddy’s Laboratories announced that Sputnik V, a registered Covid-19 vaccine in Russia, has succeeded in a phase 2 trial in India ... Read More

India approves Serum Institute’s Covishield and Bharat Biotech’s Covaxin vaccines

pharmanewsdaily- January 3, 2021 0

The Drugs Controller General of India (DCGI) has granted emergency approvals to Serum Institute of India’s Covishield and Bharat Biotech's Covaxin vaccines for the prevention ... Read More

India approves Serum Institute’s Covishield and Bharat Biotech’s Covaxin vaccines

pharmanewsdaily- January 3, 2021 0

The Drugs Controller General of India (DCGI) has granted emergency approvals to Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin vaccines for the prevention ... Read More

Swissmedic authorizes use of BNT162b2 Covid-19 vaccine from Pfizer, BioNTech

pharmanewsdaily- December 20, 2020 0

Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the use of the BNT162b2 Covid-19 vaccine from US pharma giant Pfizer and German biotech company ... Read More

Lilly to launch pragmatic study of Covid-19 drug candidate bamlanivimab in New Mexico

pharmanewsdaily- December 19, 2020 0

Eli Lilly and Company (Lilly) has revealed plans to launch a new pragmatic study of bamlanivimab (LY-CoV555) in high-risk patients with Covid-19, in partnership with ... Read More

Pfizer and BioNTech secure FDA EUA for BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 11, 2020 0

BNT162b2 FDA EUA : Pfizer and BioNTech have been granted emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for BNT162b2, their ... Read More

Lilly signs $375m deal to supply Covid-19 candidate bamlanivimab to US govt

pharmanewsdaily- October 29, 2020 0

Eli Lilly and Company (Lilly) has signed a $375 million deal with the US government for the supply of 300,000 vials of bamlanivimab (LY-CoV555) 700mg, ... Read More